RGEN vs TT · P/E 143, rev $204.1M vs P/E 36, rev $11.32B
Repligen Corporation (RGEN) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Latest reported TT revenue for 2026-06-30 was $11.32B. Net income was $1.51B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
RGEN currently screens at market cap $7.43B and trailing P/E 143.1. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the RGEN and TT stock pages for the full models.
Not investment advice.